Figures & data
Table 1 Efficacy and Safety Outcomes
Figure 1 Patient disposition.
Notes:
aPatients were still included in the analysis and enrolled in long-term follow-up due to completion of most of the treatment period. bOne patient was excluded from efficacy analysis due to receipt of placebo in 5 of 13 doses.
Abbreviation: BCC, basal cell carcinoma.
Abbreviation: BCC, basal cell carcinoma.
![Figure 1 Patient disposition.](/cms/asset/53ef1ad2-6485-4636-974d-48e1ae6165c9/dcci_a_12161600_f0001_b.jpg)